Myriad Genetics

Myriad Genetics Reviews

53 Reviews
53 Reviews
Rating Trends

Recommend to a friend
Approve of CEO
Myriad Genetics President, CEO, and Director Peter D. Meldrum
Peter D. Meldrum
34 Ratings

    Highly innovative and focused towards the future

    • Comp & Benefits
    • Work/Life Balance
    • Senior Management
    • Culture & Values
    • Career Opportunities
    Current Employee - Anonymous Employee
    Current Employee - Anonymous Employee

    I have been working at Myriad Genetics (more than 3 years)


    -best products in the industry
    -strong benefits
    -work life balance


    growing pains - still working through transition to new products

    Advice to ManagementAdvice

    Continue to share your vision with all levels of the organization

    Positive Outlook
    Approves of CEO

Myriad Genetics Interviews

Updated Oct 27, 2014
Updated Oct 27, 2014

Interview Experience

Interview Experience


Getting an Interview

Getting an Interview


Interview Difficulty


Interview Difficulty




    Senior Recruiter Interview

    Anonymous Interview Candidate
    Anonymous Interview Candidate
    Application Details

    I applied online – interviewed at Myriad Genetics.

    Interview Details

    Myriad is using digital interviews now as a way to screen their candidates. Managers are still getting familiar with this new tool. Turn around time has been quicker since they rolled this out

    Interview Questions
    • Would you be willing to put together a 5-10 presentation and present to the team.   Answer Question
    Negotiation Details
    it was a very fair process - salary seems very competitive with the market in Salt Lake
    Accepted Offer
    Positive Experience
    Average Interview

Myriad Genetics Awards & Accolades

Something missing? Add an award
America's 100 Best Small Companies, Forbes, 2013
America's Best Small Companies, Forbes, 2014
Show More

Additional Info

Unlock Profile
Headquarters Salt Lake City, UT
Size 1000 to 5000 Employees
Founded 1991
Type Company - Public (MYGN)
Industry Biotech & Pharmaceuticals
Revenue $500 million to $1 billion (USD) per year
Competitors Unknown

There are a myriad of diseases out there, and Myriad Genetics is working to detect which ones you might develop based on your genes. The company develops and sells molecular diagnostic tests in three main areas: predictive medicine (to assess a patient's risk for developing disease), personalized medicine (to identify likelihood of drug response to therapies), and prognostic medicine (to assess risk of disease progression or recurrence). Its biggest revenue maker, BRACAnalysis, helps determine risk for breast or ovarian cancer. Myriad Genetics markets its products in the... More

Work at Myriad Genetics? Share Your Experiences

Myriad Genetics

Click to Rate